Literature DB >> 1936156

The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome.

H Chart1, T Cheasty, D Cope, R J Gross, B Rowe.   

Abstract

Sera from patients with yersiniosis, shown to contain antibodies to Yersinia enterocolitica O9; and sera from patients with haemolytic uraemic syndrome (HUS) caused by Escherichia coli O157, were used to investigate serological cross-reactions between Y. enterocolitica O9 and E. coli O157. Lipopolysaccharide (LPS) was isolated from strains of Y. enterocolitica O9 and E. coli O157 and reacted with sera by immunoblotting and ELISA. Sera from patients with HUS contained antibodies to the LPS of E. coli O157 only; 80% of sera from patients with yersiniosis contained antibodies to the LPS of Y. enterocolitica O9 and E. coli O157. This one-way cross-reaction was also detected using hyperimmune rabbit antisera.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936156      PMCID: PMC2272054          DOI: 10.1017/s0950268800048986

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  18 in total

Review 1.  Isolation and identification of Yersinia enterocolitica and the Yersinia enterocolitica-like bacteria.

Authors:  A Gilmour; S J Walker
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1988

2.  Bacterial antigenic cross-reactions and haemolytic uraemic syndrome.

Authors:  H Chart; S M Scotland; B Rowe
Journal:  Lancet       Date:  1988-08-27       Impact factor: 79.321

3.  Clinical relevance of a serological cross-reaction between Escherichia coli O157 and Brucella abortus.

Authors:  R H Notenboom; A Borczyk; M A Karmali; L M Duncan
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

4.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

5.  Identification of a serological cross-reaction between Brucella abortus and Escherichia coli 0:157.

Authors:  F A Stuart; M J Corbel
Journal:  Vet Rec       Date:  1982-02-27       Impact factor: 2.695

6.  Naturally occurring antibodies in human sera that react with the iron-regulated outer membrane proteins of Escherichia coli.

Authors:  E Griffiths; P Stevenson; R Thorpe; H Chart
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

7.  Structure of the O-chain polysaccharide of the phenol-phase soluble lipopolysaccharide of Escherichia coli 0:157:H7.

Authors:  M B Perry; L MacLean; D W Griffith
Journal:  Biochem Cell Biol       Date:  1986-01       Impact factor: 3.626

8.  Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype O:9.

Authors:  M Caroff; D R Bundle; M B Perry
Journal:  Eur J Biochem       Date:  1984-02-15

9.  Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes.

Authors:  S M Scotland; B Rowe; H R Smith; G A Willshaw; R J Gross
Journal:  J Med Microbiol       Date:  1988-04       Impact factor: 2.472

10.  Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome.

Authors:  H Chart; S M Scotland; B Rowe
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

View more
  5 in total

1.  Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England.

Authors:  J Evans; R M Chalmers; H Chart; R L Salmon; S M Kench; T J Coleman; D Meadows; P Morgan-Capner; P Softley; M Sillis; D R Thomas
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Escherichia coli O157 somatic antigen is present in an isolate of E. fergusonii.

Authors:  Narelle Fegan; Robert Steven Barlow; Kari Steven Gobius
Journal:  Curr Microbiol       Date:  2006-05-09       Impact factor: 2.188

3.  Microarray analysis of microbial virulence factors.

Authors:  V Chizhikov; A Rasooly; K Chumakov; D D Levy
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

4.  Identification of a Campylobacter jejuni protein that cross-reacts with cholera toxin.

Authors:  M John Albert; Shilpa Haridas; David Steer; Gursev S Dhaunsi; A Ian Smith; Ben Adler
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

Review 5.  Escherichia coli serotype O157:H7: novel vehicles of infection and emergence of phenotypic variants.

Authors:  P Feng
Journal:  Emerg Infect Dis       Date:  1995 Apr-Jun       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.